What is the effect of Atropine on gastrointestinal motility?

Atropine is an anticholinergic medication that blocks the action of the neurotransmitter acetylcholine at muscarinic receptors, which are found throughout the gastrointestinal (GI) tract. By inhibiting these receptors, atropine reduces the activity of the parasympathetic nervous system, which is responsible for stimulating gastrointestinal motility.

The decrease in motility occurs because the parasympathetic system typically enhances peristalsis and secretions in the intestines. When atropine is administered, this enhancement is diminished, leading to a reduction in the overall movement of the digestive tract and slowing down the processes of digestion and absorption.

This pharmacological effect of atropine is particularly useful in clinical situations where it is necessary to reduce secretions or motility, such as during surgical procedures or in the treatment of certain types of poisonings. Therefore, the correct choice reflects the decreased motility resulting from the use of atropine in the gastrointestinal system.